FT

Moderna produces Covid-19 shot targeting variant discovered in South Africa

US biotech is preparing for a clinical trial to gauge effectiveness on the 501.V2 strain

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button